SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-123613
Filing Date
2022-04-27
Accepted
2022-04-27 16:10:06
Documents
6
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d313295ddef14a.htm DEF 14A 383571
2 GRAPHIC g313295g001.jpg GRAPHIC 102385
3 GRAPHIC g313295g002.jpg GRAPHIC 57708
4 GRAPHIC g313295g00a42.jpg GRAPHIC 75997
5 GRAPHIC g313295krueger.jpg GRAPHIC 19488
6 GRAPHIC g313295mohan.jpg GRAPHIC 23230
  Complete submission text file 0001193125-22-123613.txt   769303
Mailing Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024
Business Address 662 ENCINITAS BLVD., STE. 250 ENCINITAS CA 92024 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40928 | Film No.: 22859643
SIC: 2834 Pharmaceutical Preparations